| Emily Ann Johnson, LCSW, SAC-IT | |
|
199 County Road Df, Juneau, WI 53039-9512 | |
| (920) 386-4094 | |
| Not Available |
| Full Name | Emily Ann Johnson |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 7 Years |
| Location | 199 County Road Df, Juneau, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285107458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 9025 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| County Of Dodge | 2466475587 | 9 |
News Archive
When a cell begins to multiply in a dangerously abnormal way, a series of death signals trigger it to self-destruct before it turns cancerous. Now, in research to appear in the August 15 issue of Genes & Development, Rockefeller University scientists have figured out a way in mice to amplify the signals that tell these precancerous cells to die. The trick: Inactivating a protein that normally helps cells to avoid self-destruction.
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to extend the maturity date of Emisphere's Convertible Promissory Note (the "Note") to February 26, 2010.
Reuters featured an interview with Afghanistan's Acting Health Minister Suraya Dalil on the sidelines of the World Health Assembly in Geneva. "Afghanistan, whose government is fighting a worsening insurgency that has dragged on for nearly a decade since the U.S.-backed overthrow of the Taliban, is also plagued by poverty, malnutrition and corruption," Reuters writes, adding that the government and donors together spend "barely" $10 per person on health annually.
Evidence from observational studies indicates that diets rich in whole grain reduce risk of obesity and other diseases related to the metabolic syndrome e.g. type 2 diabetes and cardio-vascular disease. The mechanisms involved are only partially elucidated. Work within HEALTHGRAIN has revealed novel insights regarding some potential mechanisms.
› Verified 3 days ago
| Entity Name | County Of Dodge |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871508515 PECOS PAC ID: 2466475587 Enrollment ID: O20060104000398 |
News Archive
When a cell begins to multiply in a dangerously abnormal way, a series of death signals trigger it to self-destruct before it turns cancerous. Now, in research to appear in the August 15 issue of Genes & Development, Rockefeller University scientists have figured out a way in mice to amplify the signals that tell these precancerous cells to die. The trick: Inactivating a protein that normally helps cells to avoid self-destruction.
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to extend the maturity date of Emisphere's Convertible Promissory Note (the "Note") to February 26, 2010.
Reuters featured an interview with Afghanistan's Acting Health Minister Suraya Dalil on the sidelines of the World Health Assembly in Geneva. "Afghanistan, whose government is fighting a worsening insurgency that has dragged on for nearly a decade since the U.S.-backed overthrow of the Taliban, is also plagued by poverty, malnutrition and corruption," Reuters writes, adding that the government and donors together spend "barely" $10 per person on health annually.
Evidence from observational studies indicates that diets rich in whole grain reduce risk of obesity and other diseases related to the metabolic syndrome e.g. type 2 diabetes and cardio-vascular disease. The mechanisms involved are only partially elucidated. Work within HEALTHGRAIN has revealed novel insights regarding some potential mechanisms.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Ann Johnson, LCSW, SAC-IT 199 County Road Df, Juneau, WI 53039-9512 Ph: () - | Emily Ann Johnson, LCSW, SAC-IT 199 County Road Df, Juneau, WI 53039-9512 Ph: (920) 386-4094 |
News Archive
When a cell begins to multiply in a dangerously abnormal way, a series of death signals trigger it to self-destruct before it turns cancerous. Now, in research to appear in the August 15 issue of Genes & Development, Rockefeller University scientists have figured out a way in mice to amplify the signals that tell these precancerous cells to die. The trick: Inactivating a protein that normally helps cells to avoid self-destruction.
Stromedix, Inc., a biotechnology company focused on innovative therapies for fibrosis and fibrotic organ failure, announced today that its lead clinical candidate STX-100 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of idiopathic pulmonary fibrosis, a debilitating and almost uniformly fatal disease in which patients experience progressive difficulty breathing due to fibrosis (scarring) of the lung.
Emisphere Technologies, Inc., a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen® Technology, today announced that Novartis Pharma AG has agreed to extend the maturity date of Emisphere's Convertible Promissory Note (the "Note") to February 26, 2010.
Reuters featured an interview with Afghanistan's Acting Health Minister Suraya Dalil on the sidelines of the World Health Assembly in Geneva. "Afghanistan, whose government is fighting a worsening insurgency that has dragged on for nearly a decade since the U.S.-backed overthrow of the Taliban, is also plagued by poverty, malnutrition and corruption," Reuters writes, adding that the government and donors together spend "barely" $10 per person on health annually.
Evidence from observational studies indicates that diets rich in whole grain reduce risk of obesity and other diseases related to the metabolic syndrome e.g. type 2 diabetes and cardio-vascular disease. The mechanisms involved are only partially elucidated. Work within HEALTHGRAIN has revealed novel insights regarding some potential mechanisms.
› Verified 3 days ago
Tyler Thompson Smith, APSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 199 County Df, Juneau, WI 53039 Phone: 920-386-3500 | |
Mrs. Vonne Mary Meussling-barnett, APSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 199 County Road Df Fl 3, Juneau, WI 53039 Phone: 920-386-4094 Fax: 920-386-3812 | |
Ms. Judith Ryan Kaspar, MSSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 199 Home Rd, Juneau, WI 53039 Phone: 920-386-3500 Fax: 920-386-3812 | |
Melissa Rose Josie, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 199 Home Rd, Hdob Clinical Services, Juneau, WI 53039 Phone: 920-386-3500 Fax: 920-386-3812 |